Literatur

Autor(en) Titel Quelle Links
Labarque V, Van Geet C Clinical practice: immune thrombocytopenia in paediatrics. European journal of pediatrics 2014, 173: 163    
Ladenstein R, Treuner J, Koscielniak E, d'Oleire F, Keim M, Gadner H, Jürgens H, Niethammer D, Ritter J, Schmidt D Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study. Cancer 1993, 71: 3647    
Ladisch S, Gadner H Treatment of Langerhans cell histiocytosis--evolution and current approaches. Br J Cancer Suppl 1994, 23: 41    
Ladisch S, Gadner H, Arico M, Broadbent V, Grois N, Jacobson A, Komp D, Nicholson H LCH-I Med Pediatr Oncol 1994, 23: 107    
Ladisch S, Gadner H, Elinder G Langerhans cell granulomatosis. Am J Surg Pathol 1997, 21: 1523    
Ladenstein R, Matthay K, Berthold F, Kogner P, Pearsan A, Frappaz D, De Bernardi B, Yamamoto K, Hartmann O What can we expect from neuroblastoma screening? Med Pediatr Oncol 1998, 31: 408    
Ladenstein R, Ambros I, Potschger U, Amann G, Urban C, Fink F, Schmitt K, Jones R, Slociak M, Schilling F, Ritter J, Berthold F, Gadner H, Ambros P Prognostic significance of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol 2001, 36: 83    
Ladenstein R, Berthold F, Ambros I, Ambros P Neuroblastome. In: Gadner H, Gaedicke G, Niemeyer R, Ritter J (Hrsg.). Pädiatrische Hämatologie und Onkologie Springer Verlag, 2006    
Ladenstein R, Poetschger U, Hartman O, Jürgens H, Koscielniak E, Dallorso G, Doz F, Dini, G Megatherapy/SCT activity in paediatric solid tumours in Europe. Bone Marrow Transplant 2006, 37 Suppl.; 149    
Ladenstein R, Whelan J, Oberlin O, Weston C, Juergens, H A prospective multicentre evaluation of intensive treatment including high-dose chemotherapy and PSCR for Ewing's tumours with extra-pulmonary metastatic disease. Results from the Euro-Ewing 99 Study. Bone Marrow Transplant 2006, 37 Suppl.; 16    
Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, van den Berg H, Dirksen U, Hjorth L, Michon J, Lewis I, Craft A, Jürgens H Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial. Journal of clinical oncology 2010, 28: 3284    
Ladenstein R, Pötschger U, Pearson ADJ, Brock P, Luksch R, Castel V, Yaniv I, Papadakis V, Laureys G, Malis J, Balwierz W, Ruud E, Kogner P, Schroeder H, de Lacerda AF, Beck-Popovic M, Bician P, Garami M, Trahair T, Canete A, Ambros PF, Holmes K, Gaze M, Schreier G, Garaventa A, Vassal G, Michon J, Valteau-Couanet D, SIOP Europe Neuroblastoma Group (SIOPEN) Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. The Lancet. Oncology 2017, 18: 500    
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN Interleukin 2 with anti-GD2 antibody ch14. 18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. The Lancet. Oncology 2018, 19: 1617    
Längler A, Spix C, Jung I, Kaatsch P Comlementary and alternative medicine (CAM) in Pediatric oncology- results of a nationwide parents-questionnaire on frequency of CAM-use. 37th SIOP Congress, Vancouver, Canada 2005    
Längler A, Herold R, Kaatsch P, Souchon R, Tautz C Kinder sind keine kleine Erwachsenen (Teil 1: Allgemeine Grundlagen der pädiatrischen Onkologie). Klinikarzt 34: 159-64, 2005    
Längler A, Spix C, Gottschling S, Graf N, Kaatsch P Parents-interview on use of complementary and alternative medicine in pediatric oncology in Germany. Klinische Pädiatrie 2005, 217: 357    
Laengler A, Spix C, Seifert G, Gottschling S, Graf N, Kaatsch P Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. European journal of cancer 2008, 44: 2233    
Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C, French Society of Pediatric Oncology Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 2003, 21: 4572    
Lampert F, Harbott J, Ludwig W, Bartram C, Ritter J, Gerein V, Neidhardt M, Mertens R, Graf N, Riehm H Acute leukemia with chromosome translocation (4;11). Blut 1987, 54: 325    
Lampert F, Harbott J, Ritterbach J, Schellong G, Ritter J, Creutzig U, Riehm H, Reiter A Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy. Cancer Genet Cytogenet 1991, 54: 277    
Lampert F, Christiansen H, Berner F, Terpe H, Berthold F Disseminated neuroblastomas under 1 year of age. J Neurooncol 1997, 31: 181    
Lampert F Langerhans cell histiocytosis. Historical perspectives. Hematol Oncol Clin North Am 1998, 12: 213    
Lanvers C, Wagner A, Dübbers A, Krümpelmann S, Würthwein G, Ritter J, Creutzig U, Blaschke G, Jürgens H, Boos J Pharmakokinetics and metabolism of low-dose ATRA in children - first observations. Haematology and Blood Transfusion 1997, 39: 565    
Langer T, Huk W, Hertzberg H, Überall M, Meier W, Korinthenberg R, Beck J Akute lymphoblastische Leukämie im Kindesalter. Dt Ärzteblatt 1998, 3058    
Langer T, Hertzberg H, Dörr H, Greil J, Beck J Prinzipien zur Erfassung von Spätfolgen. Leitlinien Kinderheilkunde und Jugendmedizin 1999,L16-L22    
Langer T, Henze G, Beck J Basic methods and the developing structure of a late effects surveillance system (LESS) in the long-term follow-up of pediatric cancer patients in Germany. For the German Late Effects Study Group in the German Society Pediatric Oncology and Hematology (GPOH). Med Pediatr Oncol 2000, 34: 348    
Langer T, Krappmann P, Kochendörfer S, Kusch M, Göbel U, Huk W, Martus P, Beck J The late effects of prophylactic CNS treatment. Prognsotic factors and treatment strategies. Acute leukemias 2001,VIII: 370    
Langebrake C, Reinhardt D, Ritter J Minimising the long-term adverse effects of childhood leukaemia therapy. Drug Saf 2002, 25: 1057    
Langer T, Führer M, Stöhr W, Dörffel W, Dörr H, Bielack S, Rossi R, Kaatsch P, Beck J Die Überlebenden einer Krebserkrankung im Kindesalter. Monatsschr Kinderheilkd 2002, 150: 942    
Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck J, Meier W CNS late-effects after ALL therapy in childhood. Part III. Med Pediatr Oncol 2002, 38: 320    
Langler A, Christaras A, Abshagen K, Krauth K, Hero B, Berthold F Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-study. Klin Pädiatr 2002, 214: 153    
Langer T, Beck J, Gravou-Apostulatou C, Lang P, Handgretinger R, Greil J Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity. Pediatr Transplant 2003, 7: 494    
Langer T, Metzler M, Reinhardt D, Viehmann S, Borkhardt A, Reichel M, Stanulla M, Schrappe M, Creutzig U, Ritter J, Leis T, Jacobs U, Harbott J, Beck J, Rascher W, Repp R Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia. Genes Chromosomes Cancer 2003, 36: 393    
Lanvers C, Reinhardt D, Dubbers A, Wagner-Bohn A, Creutzig U, Ritter J, Boos J Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia. Med Pediatr Oncol 2003, 40: 293    
Langer T, Führer M, Stöhr W, Dörffel W, Dörr H, Bielack S, Rossi R, Kaatsch P, Beck J Die Überlebenden einer Krebserkrankung im Kindesalter. Monatsschr Kinderheilkd 2004, 150: 942    
Langer T, Stohr W, Bielack S, Paulussen M, Treuner J, Beck J Late effects surveillance system for sarcoma patients. Pediatr Blood Cancer 2004, 42: 373    
Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring. Cytometry. Part B, Clinical cytometry 2005, 63: 1    
Langebrake C, Creutzig U, Reinhardt D Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts. Klinische Padiatrie 2005, 217: 126    
Langer T, Dörr HG, Bielack S, Jürgens H, Göbel U, Willich N and Beck JD Spätfolgen in der Nachsorge von krebskranken Kindern und Jugendlichen. Der Onkologe 2005, 11: 1101    
Langer T, Stöhr W, Paulides M, Kremers A, Dorr HG, Göbel U, Beck JD Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS). Klinische Pädiatrie 2005, 217: 176    
Lanvers-Kaminsky C, Winter B, Koling S, Frodermann B, Braun Y, Schaefer KL, Diallo R, Koenemann S, Wai D, Willich N, Poremba C, Schuck A Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo. Oncology reports 2005, 14: 751    
Langebrake C, Creutzig U, Dworzak M, Hrusak O, Mejstrikova E, Griesinger F, Zimmermann M, Reinhardt D Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group. Journal of clinical oncology 2006, 24: 3686    
Lanvers-Kaminsky C, Nolting DM, Koster J, Schroder A, Sandkotter J, Boos J In-vitro toxicity of Ukrain against human Ewing tumor cell lines. Anti-cancer drugs 2006, 17: 1025    
Lanvers-Kaminsky C, Bremer A, Dirksen U, Jürgens H, Boos J Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines. Anti-cancer drugs 2006, 17: 657    
Langer T, Dörr H-G, Beck J-D Spätfolgen der Erkrankung und Therapie. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 1085    
Langer T, Paulides M Nachsorge von krebskranken Kindern, Jugendlichen und jungen Erwachsenen - Erkennen, Vermeiden und Behandeln von Spätfolgen. Leitlinien für die Diagnostik und Therapie in der Pädiatrischen Onkologie und Hämatologie AWMF online 2007    
Lanino E, Sacchi N, Peters C, Giardino S, Rocha V, Dini G, EBMT Paediatric, Acute Leukemia Working Parties, Eurocord Strategies of the donor search for children with second CR ALL lacking a matched sibling donor. Bone marrow transplantation 2008, 41 Suppl 2:S75    
Landmann E, Oschlies I, Zimmermann M, Moser O, Graf N, Suttorp M, Greiner J, Reiter A, Berlin-Frankfurt-Münster group Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL. British journal of haematology 2008, 143: 387    
Langer T, Meitert J, Dörr H-G, Beck J-D, Paulides M Langzeitfolgen von onkologischen Erkrankungen bei Kindern - Erkennen, Vermeiden und Behandeln von Spätfolgen. Im Focus Onkologie 7-8, 2011    
Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. Journal of clinical oncology 2012 Sep 10; 30: 3187    
Langer T, Am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O Understanding platinum-induced ototoxicity. Trends in pharmacological sciences 2013, 34: 458    
Lange J, Lenz G, Burkhardt B Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications. Expert review of hematology 2017, 10: 123    
Landmann E, Burkhardt B, Zimmermann M, Meyer U, Woessmann W, Klapper W, Wrobel G, Rosolen A, Pillon M, Escherich G, Attarbaschi A, Beishuizen A, Mellgren K, Wynn R, Ratei R, Plesa A, Schrappe M, Reiter A, Bergeron C, Patte C, Bertrand Y Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma. Haematologica 2017, 102: 2086    
Lauten M, Stanulla M, Zimmermann M, Welte K, Riehm H, Schrappe M Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter. Klin Pädiatr 2001, 213: 169    
Lauten M, Matthias T, Stanulla M, Beger C, Welte K, Schrappe M Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes. Leukemia 2002, 16: 1437    
Laupert A, Bodenmüller-Kroll R, Böttcher M, Overkamp F, Wiedemann GJ Fortbildung für Arzthelferinnen in onkologischen Schwerpunktpraxen - eine Bilanz. In|Fo|Onkologie 2003, 2: 82    
Lauten M, Asgedom G, Welte K, Schrappe M, Stanulla M Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia. haematologica 2003, 88: 353    
Lauten M, Beger C, Gerdes K, Asgedom G, Kardinal C, Welte K, Schrappe M Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia. Leukemia 2003, 17: 1551    
Lauten M, Cario G, Asgedom G, Welte K, Schrappe M Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. haematologica 2003, 88: 1253    
Lauten M, Möricke A, Beier R, Zimmermann M, Stanulla M, Meissner B, Odenwald E, Attarbaschi A, Niemeyer C, Niggli F, Riehm H, Schrappe M Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the trial ALL-BFM 95. Differential effects in precursor B-cell and T-cell leukemia. Haematologica 2012, Epub ahead of print    
Lawrenz-Wolf B, Wolfrom C, Frickel C, Fengler R, Wehinger H, Henze G Severe renal impairment of methotrexate elimination after high dose therapy. Klin Pädiatr 1994, 206: 319    
Laws H, Burdach S, van Kaick B, Engel B, Dirksen U, Körholz D, Pape H, Kahn T, Merck H, Schmitz M, Heyll A, Jürgens H, Göbel U Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report. Strahlenther Onkol 1999, 175: 488    
Laws HJ, Lehrnbecher T Therapie von Infektionen in der Kinderonkologie. Klin Pädiatr 2005, 217 Suppl 1: 1    
Laws HJ, Lehrnbecher T, Meisel R Wer soll wann, wogegen und womit geimpft werden? Impfstrategien bei Kindern nach onkologischer Therapie. WIR 2005, 3    
Laws HJ, Ammann RA, Lehrnbecher T Diagnostic procedures and management of fever in pediatric cancer patients. Klin Pädiatr 2005, 217 Suppl 1:S9    
Laws HJ, Janssen G, Borkhardt A Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia. Hamostaseologie 2009, 29: 171    
Lawitschka A, Ball L, Peters C Nonpharmacologic treatment of chronic graft-versus-host disease in children and adolescents. Biology of blood and marrow transplantation 2012, 18(1 Suppl):S74-81.    
Law N, Greenberg M, Bouffet E, Taylor MD, Laughlin S, Strother D, Fryer C, McConnell D, Hukin J, Kaise C, Wang F, Mabbott DJ Clinical and neuroanatomical predictors of cerebellar mutism syndrome. Neuro-oncology 2012, 14: 1294    
Lawitschka A, Faraci M, Yaniv I, Veys P, Bader P, Wachowiak J, Socie G, Aljurf MD, Arat M, Boelens JJ, Duarte R, Tichelli A, Peters C Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP. Bone marrow transplantation 2015, epub ahead of print    
Lawitschka A, Lucchini G, Strahm B, Dalle JH, Balduzzi A, Gibson B, Diaz De Heredia C, Wachowiak J, Dalissier A, Vettenranta K, Yaniv I, Bordon V, Bauer D, Bader P, Meisel R, Peters C, Corbacioglu S, European Society for Blood, Marrow Transplantation (EBMT) Pediatric Diseases Working Party Pediatric acute graft-versus-host disease prophylaxis and treatment: surveyed real-life approach reveals dissimilarities compared to published recommendations. Transplant international 2020, Epup ahead of print    
Laws HJ, Baumann U, Bogdan C, Burchard G, Christopeit M, Hecht J, Heininger U, Hilgendorf I, Kern W, Kling K, Kobbe G, Külper W, Lehrnbecher T, Meisel R, Simon A, Ullmann A, de Wit M, Zepp F Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie. Bundesgesundheitsblatt 2020, 63: 588    
Laws H, Baumann U, Bogdan C et al. Impfen bei Immundefizienz. Bundesgesundheitsbl 2020, 63, 588    
Leahey AM, Teunissen H, Friedman DL, Moshang T, Lange BJ, Meadows AT Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol 1999, 32: 163    
Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A Propranolol for severe hemangiomas of infancy. The New England journal of medicine 2008, 358: 2649    
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ A randomized, controlled trial of oral propranolol in infantile hemangioma. The New England journal of medicine 2015, 372: 735    
Le Deley MC, Rosolen A, Williams DM, Horibe K, Wrobel G, Attarbaschi A, Zsiros J, Uyttebroeck A, Marky IM, Lamant L, Woessmann W, Pillon M, Hobson R, Mauguen A, Reiter A, Brugières L Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial. Journal of clinical oncology 2010, 28: 3987    
Le Deley MC, Paulussen M, Lewis I, Brennan B, Ranft A, Whelan J, Le Teuff G, Michon J, Ladenstein R, Marec-Bérard P, van den Berg H, Hjorth L, Wheatley K, Judson I, Jürgens H, Craft A, Oberlin O, Dirksen U Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial. Journal of clinical oncology 2014, 32: 2440    
Lefkowitz IB, Packer RJ, Siegel KR, Sutton LN, Schut L, Evans AE Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine. Cancer 1990 Feb 1; 65: 412    
Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Groll A, Klingebiel T Infectious Complications in Children with AML. Blood 2002, 100: 244b-244b    
Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U Infectious complications in pediatric acute myeloid leukemia. Leukemia 2004, 18: 72    
Lehrnbecher T, Laws HJ Infektionen in der pädiatrischen Hämatologie und Onkologie, in Laws HJ, Lehrnbecher T: Therapie von Infektionen in der Kinderonkologie. Klin Pädiatr 2005, 217 [S1]: 3    
Lehrnbecher T, Bernig T, Hanisch M, Koehl U, Behl M, Reinhardt D, Creutzig U, Klingebiel T, Chanock SJ, Schwabe D Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 2005, 19: 1745    
Lehrnbecher T, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Creutzig U Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood 2007, 109: 936    
Lehrnbecher T, Salzmann-Manrique E, Soerensen J, Beutel K, Janka G, Gadner H, Minkov M Variant alleles of cytokine genes influence risk and clinical course of Langerhans cell histiocytosis. British journal of haematology 2011,Epub ahead of print    
Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, Hakim H, Santolaya M, Castagnola E, Davis BL, Dupuis LL, Gibson F, Groll AH, Gaur A, Gupta A, Kebudi R, Petrilli S, Steinbach WJ, Villarroel M, Zaoutis T, Sung L, International Pediatric Fever and Neutropenia Guideline Panel Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012, 30: 4427    
Lehmberg K, Grosse R, Muckenthaler MU, Altamura S, Nielsen P, Schmid H, Graubner U, Oyen F, Zeller W, Schneppenheim R, Janka GE Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients. Annals of hematology 2013, 92: 387    
Lehmberg K, Ehl S Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. British journal of haematology 2013, 160: 275    
Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Längler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol 2015, 170: 539    
Lehmberg K, Nichols KE, Henter JI, Girschikofsky M, Greenwood T, Jordan M, Kumar A, Minkov M, La Rosée P, Weitzman S Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica 2015, 100: 997    
Lehmberg K, Ehl S Hämophagozytische Lymphohistiozytose. Pädiatrische Hämatologie und Onkologie, Hrsg: A. Eggert, C. Niemeyer, Springer Verlag 2. Auflage 2018    
Leiper A Non-endocrine late complications of bone marrow transplantation in childhood. British J Haemato 2002, 118: 3    
Leidinger B, Bielack S, Koehler G, Vieth V, Winkelmann W, Gosheger G High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature. Journal of cancer research and clinical oncology 2004, 130: 357    
Leidig E Rehabilitation in der pädiatrischen Onkologie (Kurzversion). Leitlinien der Fachgesellschaft Rehabilitation in der Kinder- und Jugendmedizin. AWMF online 2008    
Deutsche Gesellschaft für Palliativmedizin S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung. AWMF    
Lennert K, Feller AC Histopathologie der Non-Hodgkin-Lymphome. Springer-Verlag 2. Aufl. 1990    
Leonard A, Wolff JE Etoposide Improves Survival in High-grade Glioma: A Meta-Analysis. Anticancer research 2013, 33: 3307    
Lerner LB Megaloblastic Anemias. In: Nelson Textbook of Pediatrics, 19th Edition - ed. by Kliegman RM, St. Geme J 2011, 448: 1655    
Leung W, Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC, Rubnitz JE, Sandlund JT, Kun LE, Bowman LC, Razzouk BI, Mathew P, Shearer P, Evans WE, Pui CH Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 2000 Sep 15; 18: 3273    
Leuschner I, Harms D, Mattke A, Koscielniak E, Treuner J Rhabdomyosarcoma of the urinary bladder and vagina. Am J Surg Pathol 2001, 25: 856    
Leung W, Sandlund JT, Hudson MM, Zhou Y, Hancock ML, Zhu Y, Ribeiro RC, Rubnitz JE, Kun LE, Razzouk B, Evans WE, Pui CH Second malignancy after treatment of childhood non-Hodgkin lymphoma. Cancer 2001, 92: 1959    
Leuschner I, Langhans I, Schmitz R, Harms D, Mattke A, Treuner J p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence. Pediatr Dev Pathol 2003, 6: 128    
Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br J Haematol 1996, 94: 82    
Lilleyman JS Management of childhood idiopathic thrombocytopenic purpura. British journal of haematology 1999, 105: 871    
Limperger V, Klostermeier UC, Kenet G, Holzhauer S, Alhenc Gelas M, Finckh U, Junker R, Heller C, Zieger B, Kurnik K, Knöfler R, Mesters R, Halimeh S, Nowak-Göttl U Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. British journal of haematology 2014, 167: 385    
Limond JA, Bull KS, Calaminus G, Kennedy CR, Spoudeas HA, Chevignard MP, Brain Tumour Quality of Survival Group, International Society of Paediatric Oncology (Europe) (SIOP-E) Quality of survival assessment in European childhood brain tumour trials, for children aged 5 years and over. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2015, 19: 202    
Linet MS, Pottern LM Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma. Cancer Res 1992, 52 : 5468    
Linden T, Oommen PT, Ueck B, Bucsky P Paediatric adrenocortical carcinoma: preliminary results of the multicentre therapy study on malignant endocrine tumours GPOH-MET 97. Pediatric Blood & Cancer 2005, 482 P. D. 112    
Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, Bellanné-Chantelot C, Vardiman JW, Caligiuri MA, Bloomfield CD, DiPersio JF, Tomasson MH, Graubert TA, Westervelt P, Watson M, Shannon W, Baty J, Mardis ER, Wilson RK, Ley TJ Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 2007, 110: 1648    
Linabery AM, Erhardt EB, Fonstad RK, Ambinder RF, Bunin GR, Ross JA, Spector LG, Grufferman S Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study. International journal of cancer 2014 Sep 15; 135: 1454    
Lion T, Haas O, Harbott J, Bannier E, Ritterbach J, Jankovic M, Fink F, Stojimirovic A, Hermann J, Riehm H, Lampert F, Ritter J, Koch H, Gadner H The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children. Blood 1992, 79: 3325    
Lion TH, Kovar H Tumorgenetik, in Gutjahr P: Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 10    
Listernick R, Louis DN, Packer RJ, Gutmann DH Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997, 41: 143    
Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, Einsele H, Gaspar HB, Gratwohl A, Passweg J, Peters C, Rocha V, Saccardi R, Schouten H, Sureda A, Tichelli A, Velardi A, Niederwieser D, European Group for Blood and Marrow Transplantation Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone marrow transplantation 2010, 45: 219    
Lobitz S, Frömmel C, Brose A, Klein J, Blankenstein O Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany. European journal of human genetics 2014, 22: 1051    
Lobitz S, Telfer P, Cela E, Allaf B, Angastiniotis M, Backman Johansson C, Badens C, Bento C, Bouva MJ, Canatan D, Charlton M, Coppinger C, Daniel Y, de Montalembert M, Ducoroy P, Dulin E, Fingerhut R, Froemmel C, Garci­a-Morin M, Gulbis B, Holtkamp U, Inusa B, James J, Kleanthous M, Klein J, Kunz JB, Langabeer L, Lapoumeoulie C, Marcao A, Marin Soria JL, McMahon C, Ohene-Frempong K, Perini JM, Piel FB, Russo G, Sainati L, Schmugge M, Streetly A, Tshilolo L, Turner C, Venturelli D, Vilarinho L, Yahyaoui R, Elion J, Colombatti R, with the endorsement of EuroBloodNet, the European Reference Network in Rare Haematological Diseases Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference. British journal of haematology 2018, 183: 648    
Locatelli F, Zecca M, Niemeyer C, Angelucci E, Arcese G, Bender-Götze C, Bonetti F, Burdach S, Dini G, Ebell W, Friedrich W, Hasle H, Hermann J, Jacobsen N, Klingebiel T, Kremens B, Mann G, Miniero R, Pession A, Peters C, Paolucci P, Rossetti F, Schmid H, Stary J, Zimmermann M Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant 1996, 18 Suppl 2: 63-8: 63    
Locatelli F, Niemeyer C, Angelucci E, Bender-Götze C, Burdach S, Ebell W, Friedrich W, Hasle H, Hermann J, Jacobsen N, Klingebiel T, Kremens B, Mann G, Pession A, Peters C, Schmid H, Stary J, Suttorp M, Uderzo C, van't Veer-Korthof E, Vossen J, Zecca M, Zimmermann M Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood. J Clin Oncol 1997, 15: 566    
Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C, Pession A, Kabisch H, Uderzo C, Bonfim CS, Bader P, Dilloo D, Stary J, Fischer A, Revesz T, Fuhrer M, Hasle H, Trebo M, van den Heuvel-Eibrink MM, Fenu S, Strahm B, Giorgiani G, Bonora MR, Duffner U, Niemeyer CM, European Working Group on Childhood MDS, European Blood and Marrow Transplantation Group Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005, 105: 410    
Locatelli F, Pagliara D Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease. Pediatric blood & cancer 2012, 59: 372    
Lode H, Reisfeld R, Handgretinger R, Nicolaou K, Gaedicke G, Wrasidlo W Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastoma. Cancer Res 1998, 58: 2925    
Lodrini M, Sprüssel A, Astrahantseff K, Tiburtius D, Konschak R, Lode HN, Fischer M, Keilholz U, Eggert A, Deubzer HE Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget 2017 Oct 17; 8: 85234    
Lodrini M, Sprüssel A, Astrahantseff K, Tiburtius D, Konschak R, Lode HN, Fischer M, Keilholz U, Eggert A, Deubzer HE Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget 2017 Oct 17; 8: 85234    
Löning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, Schrappe M Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood. Blood 2000, 95: 2770    
Löbel U, Trah J, Escherich G Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemia. Pediatr Blood Cancer 2015, 62: 539    
Lohmann DR, Brandt B, Passarge E, Horsthemke B [Molecular genetics and diagnosis of retinoblastoma. Significance for ophthalmologic practice]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 1997, 94: 263    
Lohmann DR, Gallie BL, Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K Retinoblastoma. 1993,    
Loh ML, Rubnitz JE TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curr Opin Hematol 2002, 9: 345    
Lohmann D Die Genetik des Retinoblastoms. WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2007, 1: 31    
Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S, Mullighan CG, Chen L, Bergstraesser E, Bueso-Ramos CE, Emanuel PD, Hasle H, Issa JP, van den Heuvel-Eibrink MM, Locatelli F, Stary J, Trebo M, Wlodarski M, Zecca M, Shannon KM, Niemeyer CM Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 2009, 114: 1859    
Lohse J, Schweigel J, Naeke A, Lee-Kirsch MA, Siegert G, Bergmann S, Kuhlisch E, Suttorp M, Knöfler R Platelet function in obese children and adolescents. Hamostaseologie 2010, 30 Suppl 1:S126    
Longoni D, D'Amico G, Gaipa G, Bernasconi S, Vulcano M, Onnis P, Niemeyer C, Allavena P, Biondi A Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells. Hematol J 2002, 3: 302    
Lones MA, Perkins SL, Sposto R, Tedeschi N, Kadin ME, Kjeldsberg CR, Wilson JF, Zwick DL, Cairo MS Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol 2002, 20: 2293    
Loncarevic IF, Hering A, Posorski N, Linden T, Hoyer H, Bucsky P Number of genomic imbalances correlates with the overall survival for adrenocortical cancer in childhood. Pediatr Blood Cancer 2008, 51: 356-62.    
London WB, Castel V, Monclair T, Ambros PF, Pearson AD, Cohn SL, Berthold F, Nakagawara A, Ladenstein RL, Iehara T, Matthay KK Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol 2011 29: 3286    
Longhi A, Bielack SS, Grimer R, Whelan J, Windhager R, Leithner A, Gronchi A, Biau D, Jutte P, Krieg AH, Klenke FM, Grignani G, Donati DM, Capanna R, Casanova J, Gerrand C, Bisogno G, Hecker-Nolting S, De Lisa M, D'Ambrosio L, Willegger M, Scoccianti G, Ferrari S Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. European journal of cancer (Oxford, England : 1990) 2017, 74: 9    
Lorenzana A, Armin S, Sharma A, Allarakhia I, Witkowski A Cerebral Infarctions After Intravenous Immunoglobulin Therapy for ITP in a Child. Pediatric neurology 2014, 50: 188    
Lo SS, Fakiris AJ, Abdulrahman R, Henderson MA, Chang EL, Suh JH, Timmerman RD Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in pediatric brain tumors. Expert review of neurotherapeutics 2008, 8: 121    
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica 2007, 114: 97    
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta neuropathologica 2016, 131: 803    
Lucarelli G, Isgro`, A, Sodani P, Gaziev, J Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia. Cold Spring Harb Perspect Med 2012, 2: a011825    
Ludwig W, Herrmann F, Gatzke A, Budde M, Creutzig U, Ritter J, Schellong G Surface marker analysis by monoclonal antibodies. Haematology and Blood Transfusion 1987, 30: 418    
Ludwig W, Bartram C, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt-Jung H, Teichmann J, Riehm H Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988, 71: 1518    
Ludwig W, Köller U, Bartram C, Harbott J, Haas O, Ritter J, Creutzig U, Gadner H, Riehm H Phenotypic and genotypic heterogeneity in infant acute leukemia. Contrib Oncol 1990, 41: 46    
Ludwig W, Thiel E, Köller U, Bartram C, Harbott J, Teichmann J, Seibt Jung H, Creutzig U, Ritter J, Riehm H Incidence and clinical implications of acute hybrid leukemia in childhood. Haematology and Blood Transfusion 1990, 33: 516    
Ludwig R, Weirich A, Potter R, Harms D, Burger D, Michaelis J, Erttmann R, Weinel P, Haas R, Ritter J, Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study. Klin Pädiatr 1992, 204: 204    
Ludwig W, Harbott J, Bartram C, Komischke B, Sperling C, Teichmann J, Seibt-Jung H, Notter M, Odenwald E, Nehmer A, Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia. Recent Results Cancer Res 1993, 131: 269    
Ludwig R, Weirich A, Bürger D, Graf N, Harms D, Kaatsch P Duchführung eines neuen Therapiekonzepts für Nephroblastome (SIOP 9/GPOH) im Bereich der Gesellschaft für Pädiatrische Onkologie und Hämatologie. Monatsschr Kinderheilkd 1997, 145: 128    
Ludwig R, Weirich A, Abel U, Hofmann W, Graf N, Tournade M Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Med Pediatr Oncol 1999, 33: 462    
Lünenbürger H, Lanvers-Kaminsky C, Lechtape B, Frühwald MC Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines. Anti-cancer drugs 2010, 21: 514    
Lueth M, Stein H, Spors B, Henze G, Driever PH First case report of a peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child. Journal of pediatric hematology/oncology 2012, 34:e66    
von Lützau P, Otto M, Hechler T, Metzing S, Wolfe J, Zernikow B Children dying from cancer: parents' perspectives on symptoms, quality of life, characteristics of death, and end-of-life decisions. Journal of palliative care 2012, 28: 274    
Lugthart S, Cheok MH, den Boer ML, Yang W, Holleman A, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer cell 2005, 7: 375    
Luzzatto L, Arese P Favism and Glucose-6-Phosphate Dehydrogenase Deficiency. The New England journal of medicine 2018, 378: 60    
Lönnerholm G, Valsecchi MG, De Lorenzo P, Schrappe M, Hovi L, Campbell M, Mann G, Janka-Schaub G, Li CK, Stary J, Hann I, Pieters R, Interfant-99 study group Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia. Pediatric blood & cancer 2009, 52: 596    
154 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.